These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 11479202)
1. Dioxin suppresses the checkpoint protein, MAD2, by an aryl hydrocarbon receptor-independent pathway. Oikawa K; Ohbayashi T; Mimura J; Iwata R; Kameta A; Evine K; Iwaya K; Fujii-Kuriyama Y; Kuroda M; Mukai K Cancer Res; 2001 Aug; 61(15):5707-9. PubMed ID: 11479202 [TBL] [Abstract][Full Text] [Related]
2. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway. Sulentic CE; Holsapple MP; Kaminski NE J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109 [TBL] [Abstract][Full Text] [Related]
3. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines. Son DS; Rozman KK Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005 [TBL] [Abstract][Full Text] [Related]
4. 2,3,7,8-Tetrachlorodibenzo-p-dioxin promotes injury-induced vascular neointima formation in mice. Guo S; Zhang R; Liu Q; Wan Q; Wang Y; Yu Y; Liu G; Shen Y; Yu Y; Zhang J FASEB J; 2019 Sep; 33(9):10207-10217. PubMed ID: 31216422 [TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor-dependent induction of loss of mitochondrial membrane potential in epididydimal spermatozoa by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Fisher MT; Nagarkatti M; Nagarkatti PS Toxicol Lett; 2005 Jun; 157(2):99-107. PubMed ID: 15836997 [TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptors in urogenital sinus mesenchyme mediate the inhibition of prostatic epithelial bud formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Ko K; Moore RW; Peterson RE Toxicol Appl Pharmacol; 2004 Apr; 196(1):149-55. PubMed ID: 15050416 [TBL] [Abstract][Full Text] [Related]
7. Role of the aryl hydrocarbon receptor and Cyp1b1 in the antiestrogenic activity of 2,3,7,8-tetrachlorodibenzo-p-dioxin. Takemoto K; Nakajima M; Fujiki Y; Katoh M; Gonzalez FJ; Yokoi T Arch Toxicol; 2004 Jun; 78(6):309-15. PubMed ID: 15004665 [TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) exposure of normal human dermal fibroblasts results in AhR-dependent and -independent changes in gene expression. Akintobi AM; Villano CM; White LA Toxicol Appl Pharmacol; 2007 Apr; 220(1):9-17. PubMed ID: 17257637 [TBL] [Abstract][Full Text] [Related]
10. Ovarian tumors in rats induced by chronic 2,3,7,8-tetrachlorodibenzo-p-dioxin treatment. Davis BJ; Mccurdy EA; Miller BD; Lucier GW; Tritscher AM Cancer Res; 2000 Oct; 60(19):5414-9. PubMed ID: 11034082 [TBL] [Abstract][Full Text] [Related]
11. 2,3,7,8-Tetrachlorodibenzo-p-dioxin elicits aryl hydrocarbon receptor-mediated apoptosis in the avian DT40 pre-B-cell line through activation of caspases 9 and 3. Puebla-Osorio N; Ramos KS; Falahatpisheh MH; Smith R; Berghman LR Comp Biochem Physiol C Toxicol Pharmacol; 2004 Aug; 138(4):461-8. PubMed ID: 15536054 [TBL] [Abstract][Full Text] [Related]
12. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity. Williamson MA; Gasiewicz TA; Opanashuk LA Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747 [TBL] [Abstract][Full Text] [Related]
13. Aryl-hydrocarbon receptor-dependent pathway and toxic effects of TCDD in humans: a population-based study in Seveso, Italy. Baccarelli A; Pesatori AC; Masten SA; Patterson DG; Needham LL; Mocarelli P; Caporaso NE; Consonni D; Grassman JA; Bertazzi PA; Landi MT Toxicol Lett; 2004 Apr; 149(1-3):287-93. PubMed ID: 15093275 [TBL] [Abstract][Full Text] [Related]
14. MAD2 expression and its significance in mitotic checkpoint control in testicular germ cell tumour. Fung MK; Cheung HW; Wong HL; Yuen HF; Ling MT; Chan KW; Wong YC; Cheung AL; Wang X Biochim Biophys Acta; 2007 Jun; 1773(6):821-32. PubMed ID: 17467818 [TBL] [Abstract][Full Text] [Related]
15. TCDD-induced alterations in gene expression profiles of the developing mouse paw do not influence morphological differentiation of this potential target tissue. Bemis JC; Alejandro NF; Nazarenko DA; Brooks AI; Baggs RB; Gasiewicz TA Toxicol Sci; 2007 Jan; 95(1):240-8. PubMed ID: 17035482 [TBL] [Abstract][Full Text] [Related]
16. Aryl hydrocarbon receptor activation in genital tubercle, palate, and other embryonic tissues in 2,3,7, 8-tetrachlorodibenzo-p-dioxin-responsive lacZ mice. Willey JJ; Stripp BR; Baggs RB; Gasiewicz TA Toxicol Appl Pharmacol; 1998 Jul; 151(1):33-44. PubMed ID: 9705885 [TBL] [Abstract][Full Text] [Related]
17. Significance of MAD2 expression to mitotic checkpoint control in ovarian cancer cells. Wang X; Jin DY; Ng RW; Feng H; Wong YC; Cheung AL; Tsao SW Cancer Res; 2002 Mar; 62(6):1662-8. PubMed ID: 11912137 [TBL] [Abstract][Full Text] [Related]
18. Differences in acute toxicity syndromes of 2,3,7,8-tetrachlorodibenzo-p-dioxin and 1,2,3,4,7,8-hexachlorodibenzo-p-dioxin in rats. Niittynen M; Simanainen U; Syrjälä P; Pohjanvirta R; Viluksela M; Tuomisto J; Tuomisto JT Toxicology; 2007 Jun; 235(1-2):39-51. PubMed ID: 17448584 [TBL] [Abstract][Full Text] [Related]
19. Toxicogenomic profile of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the murine fetal heart: modulation of cell cycle and extracellular matrix genes. Thackaberry EA; Jiang Z; Johnson CD; Ramos KS; Walker MK Toxicol Sci; 2005 Nov; 88(1):231-41. PubMed ID: 16120747 [TBL] [Abstract][Full Text] [Related]
20. Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity. Fisher MT; Nagarkatti M; Nagarkatti PS Toxicol Sci; 2004 Mar; 78(1):116-24. PubMed ID: 14718646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]